Corinne Summers

2.2k total citations · 1 hit paper
42 papers, 1.5k citations indexed

About

Corinne Summers is a scholar working on Oncology, Hematology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Corinne Summers has authored 42 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Oncology, 12 papers in Hematology and 8 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Corinne Summers's work include CAR-T cell therapy research (30 papers), Hematopoietic Stem Cell Transplantation (9 papers) and Acute Lymphoblastic Leukemia research (8 papers). Corinne Summers is often cited by papers focused on CAR-T cell therapy research (30 papers), Hematopoietic Stem Cell Transplantation (9 papers) and Acute Lymphoblastic Leukemia research (8 papers). Corinne Summers collaborates with scholars based in United States, Australia and Canada. Corinne Summers's co-authors include Colleen Annesley, Michael C. Jensen, Julie R. Park, Olivia Finney, Kasey J. Leger, Marie Bleakley, Hannah Brakke, Rebecca Gardner, Stephanie Mgebroff and Catherine Lindgren and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Frontiers in Immunology.

In The Last Decade

Corinne Summers

39 papers receiving 1.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Intent-to-treat leukemia remission by CD19 CAR T cells of defined formulation and dose in children and young adults

2017 787 citations Rebecca Gardner, Olivia Finney et al. Blood profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Corinne Summers United States	15	1.3k	411	343	319	253	42	1.5k
Hannah Brakke United States	5	1.3k 1.0×	393 1.0×	387 1.1×	343 1.1×	226 0.9×	5	1.4k
Colleen Annesley United States	19	1.5k 1.1×	450 1.1×	392 1.1×	445 1.4×	305 1.2×	52	1.8k
Christopher Brown United States	12	1000 0.8×	319 0.8×	287 0.8×	248 0.8×	197 0.8×	20	1.1k
Peihua Lu China	18	1.2k 0.9×	356 0.9×	229 0.7×	380 1.2×	553 2.2×	74	1.6k
Nicholas Tschernia United States	7	2.1k 1.6×	656 1.6×	558 1.6×	590 1.8×	614 2.4×	20	2.3k
Sherry Adkins United States	9	1.9k 1.4×	472 1.1×	543 1.6×	451 1.4×	503 2.0×	14	2.1k
Colette Chaney United States	13	1.3k 1.0×	432 1.1×	293 0.9×	380 1.2×	733 2.9×	19	1.7k
Haneen Shalabi United States	15	777 0.6×	222 0.5×	184 0.5×	172 0.5×	124 0.5×	47	866
Margherita Norelli Italy	6	1.2k 0.9×	352 0.9×	395 1.2×	388 1.2×	458 1.8×	9	1.5k
David E Ambrose United States	6	1.3k 1.0×	366 0.9×	408 1.2×	377 1.2×	442 1.7×	10	1.4k

Countries citing papers authored by Corinne Summers

Since Specialization

Citations

This map shows the geographic impact of Corinne Summers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Corinne Summers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Corinne Summers more than expected).

Fields of papers citing papers by Corinne Summers

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Corinne Summers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Corinne Summers. The network helps show where Corinne Summers may publish in the future.

Co-authorship network of co-authors of Corinne Summers

This figure shows the co-authorship network connecting the top 25 collaborators of Corinne Summers. A scholar is included among the top collaborators of Corinne Summers based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Corinne Summers. Corinne Summers is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Li, Yimei, Yang Qiao, Jordan Gauthier, et al.. (2025). A Novel R Shiny Tool TVCurveTM for Survival Analysis with Time-Varying Covariate in Oncology Clinical Studies: Overcoming Biases and Enhancing Collaboration. Transplantation and Cellular Therapy. 31(2). S23–S24.

Annesley, Colleen, Kristy Seidel, Qian Wu, et al.. (2025). Outcomes of PLAT-02 and PLAT-03: Evaluating CD19 CAR T-Cell Therapy and CD19-expressing T-APC Support in Pediatric B-ALL. Blood. 146(7). 789–801. 2 indexed citations

Stratton, Kelly G., Jenny L. Smith, Michael C. Jensen, et al.. (2025). Low Peripheral Blood Counts and Elevated Proinflammatory Cytokines Signal a Poor CD19 Chimeric Antigen Receptor T-cell Response in Acute Lymphoblastic Leukemia. Transplantation and Cellular Therapy. 31(8). 551–564. 1 indexed citations

Steineck, Angela, Elad Jacoby, Allison Barz Leahy, et al.. (2025). Access to CARe: A Narrative of Real‐World Medical Decision‐Making to Access Chimeric Antigen Receptor (CAR) T‐Cell Therapy in Children, Adolescents, and Young Adults. Pediatric Blood & Cancer. 72(4). e31516–e31516.

Carpenter, Paul A., Theodore A. Gooley, Catherine J. Lee, et al.. (2024). Decreasing chronic graft-versus-host disease rates in all populations. Blood Advances. 8(22). 5829–5837. 6 indexed citations

Annesley, Colleen, Adam J. Lamble, Corinne Summers, et al.. (2024). Feasibility and favorable responses after investigational CAR T-cell therapy for relapsed and refractory infant ALL. Blood Advances. 9(9). 2068–2078. 2 indexed citations

Choe, Michelle & Corinne Summers. (2024). The Road More or Less Traveled- Examining the Role of Consolidative Allogeneic Hematopoietic Stem Cell Transplantation After Chimeric Antigen Receptor T Cell Therapy in B-cell ALL. Seminars in Hematology. 61(5). 314–320. 1 indexed citations

Summers, Corinne, Karen M. Chisholm, Sandra D. Bohling, et al.. (2023). Plasticity of lineage switch in B-ALL allows for successful rechallenge with CD19-directed immunotherapy. Blood Advances. 7(12). 2825–2830. 4 indexed citations

Lamble, Adam J., Amy Moskop, Michael A. Pulsipher, et al.. (2023). INSPIRED Symposium Part 2: Prevention and Management of Relapse Following Chimeric Antigen Receptor T Cell Therapy for B Cell Acute Lymphoblastic Leukemia. Transplantation and Cellular Therapy. 29(11). 674–684. 8 indexed citations

10.

Ceppi, Francesco, Ashley Wilson, Colleen Annesley, et al.. (2022). Modified Manufacturing Process Modulates CD19CAR T-cell Engraftment Fitness and Leukemia-Free Survival in Pediatric and Young Adult Subjects. Cancer Immunology Research. 10(7). 856–870. 14 indexed citations

11.

Suskind, David L., Dale Lee, Namita Singh, et al.. (2022). Adjunctive Dietary Therapy Is Associated With Improved Gastrointestinal Symptoms in Steroid‐Refractory Gastrointestinal Graft‐Versus‐Host Disease. JPGN Reports. 3(2). e203–e203. 2 indexed citations

12.

Summers, Corinne, Colleen Annesley, Jason K. Yokoyama, et al.. (2021). CD22 CAR Optimization for Improved in-Human Activity Following Inadequate CD22 CAR Activity in Phase 1 Clinical Trial PLAT-04. Blood. 138(Supplement 1). 403–403. 4 indexed citations

13.

Summers, Corinne, Qian Wu, Colleen Annesley, et al.. (2021). Hematopoietic Cell Transplantation after CD19 Chimeric Antigen Receptor T Cell-Induced Acute Lymphoblastic Leukemia Remission Confers a Leukemia-Free Survival Advantage. Transplantation and Cellular Therapy. 28(1). 21–29. 44 indexed citations

14.

Annesley, Colleen, Corinne Summers, Michael A. Pulsipher, et al.. (2021). SCRI-CAR19x22v2 T Cell Product Demonstrates Bispecific Activity in B-ALL. Blood. 138(Supplement 1). 470–470. 16 indexed citations

15.

Steineck, Angela, Lori Wiener, Jennifer W. Mack, et al.. (2020). Psychosocial care for children receiving chimeric antigen receptor (CAR) T‐cell therapy. Pediatric Blood & Cancer. 67(5). e28249–e28249. 12 indexed citations

16.

Summers, Corinne, Vipul Sheth, & Marie Bleakley. (2020). Minor Histocompatibility Antigen-Specific T Cells. Frontiers in Pediatrics. 8. 284–284. 20 indexed citations

17.

Dahlberg, Ann, Wendy M. Leisenring, Marie Bleakley, et al.. (2019). Prognosis of relapse after hematopoietic cell transplant (HCT) for treatment of leukemia or myelodysplastic syndrome (MDS) in children. Bone Marrow Transplantation. 54(8). 1337–1345. 17 indexed citations

18.

Ceppi, Francesco, Colleen Annesley, Olivia Finney, et al.. (2018). Minimal Change in CAR T Cell Manufacturing Can Impact in Expansion and Side Effect of the CAR T Cell Therapy. Blood. 132(Supplement 1). 4012–4012. 5 indexed citations

19.

Gardner, Rebecca, Olivia Finney, Hannah Smithers, et al.. (2016). CD19CAR T Cell Products of Defined CD4:CD8 Composition and Transgene Expression Show Prolonged Persistence and Durable MRD-Negative Remission in Pediatric and Young Adult B-Cell ALL. Blood. 128(22). 219–219. 31 indexed citations

20.

Summers, Corinne, Filippo Milano, Ted Gooley, Ann Dahlberg, & Colleen Delaney. (2014). Infusion of Ex Vivo Expanded Cord Blood Progenitor Cells Reduces the Risk of Bacteremia after Myeloablative Cord Blood Transplant. Blood. 124(21). 3860–3860. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact